HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate

This article was originally published in The Rose Sheet

Executive Summary

Dentifrice brand sales total $469.2 mil. in the 52-weeks ending March 26, a 27.9% dollar share, according to data provided to the company by Chicago-based Information Resources, Inc. North American sales reached $537.6 mil. in the first quarter. Net sales rose 3.1% to $2.24 bil. and net income increased 14.8% to $239.9 mil. Colgate Sparkling White toothpaste with "high cleaning silica with micro-cleaning crystals" will be on shelves May 8. The mint-flavored whitening dentifrice will come in Tartar Control and Baking Soda & Peroxide formulas. A 7.8 oz. and 6 oz. tube will retail for $3.49 and $2.99, respectively. Print, TV and Internet advertising will break in June, as well as FSIs with coupons and in-store displays

You may also be interested in...



Colgate 2in1 Toothpaste/Mouthwash Combo Opens New Oral Care Category

Colgate 2in1 Toothpaste and Mouthwash, which combines ingredients from both formulas in a light, foaming gel, will be launched in September, Colgate-Palmolive said.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007921

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel